Prescription and Drug Interaction Errors Under Georgia Law

Is a medication error just one kind of mistake? It is not, and the difference matters more than it might seem. Deciding what to prescribe is a clinical judgment, made by a prescriber weighing a patient’s conditions, other medications, and risks. Physically handing over or administering that medication is a separate act, governed by a separate standard. This article is about the first: the prescribing decision itself, where errors involve the wrong drug, the wrong dose, or a dangerous interaction that should have been caught.

This article explains prescription errors in general terms and is not legal advice. Whether a specific situation supports a claim is a question for a licensed Georgia attorney.

The prescribing standard of care

Prescribing is a clinical decision, and it carries its own standard of care. Under O.C.G.A. § 51-1-27, a provider must exercise the reasonable degree of skill and care accepted in the profession, and for prescribing that means the accepted practice for selecting and dosing medications safely.

That standard covers a range of judgments: choosing an appropriate medication for the condition, accounting for the patient’s other drugs and allergies, calculating a safe dose, and recognizing contraindications. Establishing whether a prescriber met the standard requires expert testimony about what accepted prescribing practice demanded in the specific clinical situation. The question is not whether a bad reaction occurred, but whether the prescribing decision itself fell below accepted practice.

Types of prescription errors

Prescribing errors cluster in a few recognizable categories, each tied to a judgment the prescriber was responsible for making:

  • Wrong medication, where the drug selected was inappropriate for the patient’s condition
  • Dosing errors, where the amount prescribed was unsafe for the patient’s age, weight, or kidney or liver function
  • Dangerous interactions, where a newly prescribed drug conflicts with another the patient was already taking
  • Ignored contraindications, where a known allergy or condition made the drug inappropriate

What unites these is that each is a failure of the prescribing judgment itself, before the medication ever reaches the patient. A prescriber who orders a drug despite a documented interaction with the patient’s existing regimen may have breached the standard, regardless of what happened at the pharmacy or bedside afterward.

The learned intermediary doctrine

Prescription cases in Georgia often involve a principle that shapes who is responsible for warning the patient about a drug’s risks. Under the learned intermediary doctrine, a drug manufacturer generally satisfies its duty to warn by warning the prescribing physician, rather than the patient directly.

The reasoning is that the prescriber stands between the manufacturer and the patient as a trained intermediary, positioned to weigh the drug’s risks against the individual patient’s needs and to communicate what matters. The doctrine has a practical consequence for malpractice claims: it places the responsibility to evaluate and convey drug risks on the prescriber. If a manufacturer adequately warned the physician, the focus of a claim turns to whether the physician properly accounted for and acted on that information. This is one reason prescribing errors are analyzed as clinical-judgment failures rather than product problems.

Who may be responsible

A prescription error can involve more than the prescriber, though the prescriber is usually central. Depending on the circumstances, responsibility for a medication-related injury may touch the prescribing physician, and in some situations others in the medication chain.

The key line this article draws is between the prescribing decision and the later act of dispensing or administering the drug, which is governed by different standards and often different parties. When the failure is in the decision of what to prescribe, the analysis centers on the prescriber’s judgment against the prescribing standard.

Common questions

Is the pharmacy responsible if a prescription error causes harm?
A pharmacy’s role is distinct from the prescriber’s, and responsibility depends on where the failure occurred. This article concerns the prescribing decision itself. Whether a pharmacy bears responsibility for a dispensing error is a separate question governed by the standards that apply to dispensing rather than prescribing.

Does the learned intermediary doctrine mean a patient cannot sue the drug manufacturer?
Not exactly. The doctrine generally means a manufacturer satisfies its duty to warn by warning the prescribing physician rather than the patient directly. It shapes where the duty to convey drug risks sits, but whether any claim against a manufacturer exists depends on the specific facts and the adequacy of the warnings provided.

What if a patient did not tell the prescriber about another medication they were taking?
The information a patient provides is relevant, and a prescriber’s ability to identify an interaction can depend on the medical history available. Whether an omission affects the analysis turns on what the prescriber knew or should have known, and on whether accepted practice would have surfaced the information through other means.

For anyone trying to understand a possible prescription error claim, a few points anchor the analysis. Identify whether the alleged error was in the prescribing decision itself, as opposed to how the drug was later dispensed or given. Recognize that the prescriber generally bears the duty to weigh and act on a drug’s known risks. And have the prescribing judgment reviewed by a qualified expert, since the standard is clinical and specific. Everything turns on separating the decision to prescribe from what happened to the drug afterward.

Leave a Reply

Your email address will not be published. Required fields are marked *